NCT04886323

Effect of Cold Atmospheric Plasma on Malassezia Folliculitis

Effect of Cold Atmospheric Plasma on Malassezia Folliculitis: a Randomized Controlled Trial

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 50 (actual)
• Sponsor: The Second Hospital of Anhui Medical University · Academic / Other
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

The cold atmospheric plasma may provide a new and effective method for the treatment of Malassezia folliculitis. The investigators conduct this randomized controlled trial to evaluate the effectiveness and safety of cold atmospheric plasma on Malassezia folliculitis. Participants entered this double-blind placebo-controlled trial will randomly assign to treatment with either cold atmospheric plasma or antifungal drugs. The differences of treatment effects of the two groups will be observed and compared.

Detailed description

Malassezia folliculitis is a common disease of young and middle-aged people. It is an inflammatory disease caused by Malassezia infection. Generally, Topical or systemic use of antifungal drugs are the first choice for treatment but sometimes are limited due to adverse drug reactions and drug resistance. Cold atmospheric plasma has an inhibitory or killing effect on pathogenic microorganisms including fungi and has no obvious adverse damage to normal tissues. The investigators conduct this randomized controlled trial to study the effect of cold atmospheric plasma on Malassezia folliculitis, and evaluate its effectiveness and safety for Malassezia folliculitis. All data are recorded and compared after the end of the experiment.

Conditions

• Malassezia Folliculitis

Interventions

Type	Name	Description
DEVICE	Cold atmospheric plasma treatment device	Treat with cold atmospheric plasma treatment device.
DRUG	Itraconazole Capsules	Treat with Itraconazole capsules

Timeline

• Start date: 2022-08-03
• Primary completion: 2023-12-17
• Completion: 2023-12-17
• First posted: 2021-05-14
• Last updated: 2023-12-26

Locations

1 site across 1 country: China